metabolic disease program (Bioleaders)

N/A

Report date: 2025/06/11 10:52:30

Base Information

Drug Namemetabolic disease program (Bioleaders)

Drug Alias Namehyperlipidemia program (Bioleaders)BLS-M201MX023BLS-MX023

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionLipid metabolism modulators

TargetsNot applicable

Therapy Area/IndicationsHyperlipidemiasMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBL Corp

China Registration ClassN/A

Active CompaniesBL Corp

Inactive CompaniesN/A

Active IndicationsHyperlipidemias

Inactive IndicationsMetabolic Diseases

ATC CodeN/A